← All companies

MPLT

MapLight Therapeutics, Inc.

MPLT Nasdaq Pharmaceutical Preparations EDGAR ↗

$12.84

-0.10 -0.81%

Key statistics

from XBRL data in SEC filings

Market cap

$545M

Revenue (TTM)

—

Net income (TTM)

-$199M

EPS (TTM)

$-18.56

P/E ratio

—

Dividend yield

—

Free cash flow

-$139M

Cash

$55.7M

Total assets

$419M

Gross margin

—

52-week range

$9.10 – $40.43

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure; Other events Jul 27, 2026 8-K Shareholder vote results Jun 24, 2026 8-K Regulation FD disclosure; Other events Jun 22, 2026 8-K Director or officer change Jun 18, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 14, 2026 8-K Director or officer change Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 9, 2026 10-Q Quarter ended 2025-09-30 Dec 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Dec 4, 2025 8-K Unregistered sale of equity; Amended charter or bylaws; Other events Oct 29, 2025

Other filings

4 Aug 4, 2026 SCHEDULE 13D/A Aug 3, 2026 144 Aug 3, 2026 SCHEDULE 13D/A Jul 31, 2026 144 Jul 30, 2026 4 Jul 30, 2026 4 Jul 28, 2026 4 Jul 20, 2026 4 Jul 20, 2026 4 Jul 17, 2026 4 Jul 17, 2026 4 Jul 17, 2026 4 Jul 17, 2026 144 Jul 17, 2026 144 Jul 17, 2026 144/A Jul 15, 2026 144 Jul 15, 2026 144 Jul 15, 2026 144 Jul 15, 2026 144 Jul 15, 2026 144 Jul 15, 2026 144 Jul 15, 2026 144 Jul 15, 2026 4 Jun 25, 2026 4 Jun 25, 2026 4 Jun 25, 2026 4 Jun 25, 2026